Editor's note: This is the second in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.
(CIDRAP News) CSL Biotherapies, the US branch of an Australian vaccine producer, announced this week it has applied for Food and Drug Administration (FDA) approval to market a seasonal influenza vaccine in the United States.
(CIDRAP News) A new test developed by federal experts offers preliminary detection of H5 avian influenza in human patients in about 4 hours, compared with 2 to 3 days for other methods, government officials announced today.
(CIDRAP News) Meat companies are again free to use most of the small intestine of cattle to make sausage casings, following a change in a federal rule intended to protect people from exposure to bovine spongiform encephalopathy (BSE), or mad cow disease.
(CIDRAP News) – British regulators have cleared Chiron Corp. to resume making influenza vaccine at its plant in Liverpool, England, which should improve the chances of an adequate vaccine supply in the United States next winter.
(CIDRAP News) To help prevent the spread of variant Creutzfeldt-Jakob disease (vCJD) in the United States, a federal advisory committee recommended yesterday that anyone who received a blood transfusion in France after 1980 should not be allowed to give blood.
(CIDRAP News) Canada's investigation of its second case of bovine spongiform encephalopathy (BSE) recently concluded with a finding that at least 110 cattle in the infected cow's birth group died or were slaughtered before that case came to light.
As part of efforts to improve the nation's long-term supply of influenza vaccine, the federal government is launching a clinical trial to help get a German-made vaccine licensed for regular use in the United States.
(CIDRAP News) The Washington state cow announced by the US Department of Agriculture (USDA) on Dec 23 to be a "presumptive positive" bovine spongiform encephalopathy (BSE) case, was born in April 1997, before the August 1997 Food and Drug Administration ban on feeding ruminant-derived meat and bone meal supplements to cattle went into effect.
(CIDRAP News) Federal officials took pains to assure the public today that the risk of contamination in the US beef supply is very low following yesterday's announcement that the nation's first apparent case of bovine spongiform encephalopathy (BSE), or mad cow disease, had turned up in Washington state.